Pyrazolopyridine inhibitors of B-Raf(V600E). Part 4: Rational design and kinase selectivity profile of cell potent type II inhibitors.
Wenglowsky, S., Moreno, D., Laird, E.R., Gloor, S.L., Ren, L., Risom, T., Rudolph, J., Sturgis, H.L., Voegtli, W.C.(2012) Bioorg Med Chem Lett 22: 6237-6241
- PubMed: 22954737 
- DOI: 10.1016/j.bmcl.2012.08.007
- Primary Citation of Related Structures:  
4G9C, 4G9R - PubMed Abstract: 
Cell potent inhibitors of B-Raf(V600E) that bind to the kinase in the DFG-out conformation are reported. These compounds utilize the hinge-binding group and lipophilic linker from a previously disclosed series of B-Raf(V600E) inhibitors that bind to the kinase in an atypical DFG-in, αC-helix-out conformation ...